Ventyx Biosciences Inc (VTYX)
4.805
-0.18
(-3.51%)
USD |
NASDAQ |
May 20, 16:00
4.805
0.00 (0.00%)
After-Hours: 20:00
Ventyx Biosciences Total Assets (Quarterly): 332.08M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 332.08M |
| December 31, 2023 | 277.69M |
| September 30, 2023 | 321.70M |
| June 30, 2023 | 348.76M |
| March 31, 2023 | 389.17M |
| December 31, 2022 | 371.40M |
| September 30, 2022 | 420.44M |
| Date | Value |
|---|---|
| June 30, 2022 | 262.18M |
| March 31, 2022 | 277.95M |
| December 31, 2021 | 291.48M |
| September 30, 2021 | 148.71M |
| June 30, 2021 | 105.92M |
| December 31, 2020 | 0.245M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.245M
Minimum
Dec 2020
420.44M
Maximum
Sep 2022
272.90M
Average
291.48M
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
| Anavex Life Sciences Corp | 144.52M |
| CERo Therapeutics Holdings Inc | -- |
| Avinger Inc | 16.86M |
| Checkpoint Therapeutics Inc | 11.98M |
| RAPT Therapeutics Inc | 155.82M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 25.08M |
| Shareholders Equity (Quarterly) | 307.00M |